Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

Hakuyosha Co. Ltd. (9731.TO) Japan Half-Year Ended June 30 GROUP 2025 2024 Revenue Y21.65 bln Y21.33 bln Operating Profit Y931.00 mln Y991.00 mln Pretax Profit Y1.00 bln Y1.09 bln Net Profit Y761.00 ...

Japan Half-Year Ended June 30 GROUP 2025 2024 Revenue Y17.11 bln Y18.28 bln Operating Profit Y328.00 mln Y1.00 mln Pretax Profit Y291.00 mln (Y6.00 mln) Net Profit Y151.00 mln Y105.00 mln Per share ...

"According to Rosstat’s preliminary estimation, GDP growth in Q2 2025 totaled 1.1% after 1.4% in Q1. In the first half of 2025 economic growth amounted to 1.2%, as assessed by Russia’s Economic ...

For the third consecutive year, Converge has once again swept all four major categories at the Ookla Speedtest Awards for the ...